<DOC>
	<DOCNO>NCT00477958</DOCNO>
	<brief_summary>RATIONALE : A study assess ability old patient think , learn , remember , make judgment , carry daily activity may help doctor plan treatment old patient cancer . PURPOSE : This clinical trial study assessment tool old patient cancer .</brief_summary>
	<brief_title>Assessment Tool Older Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine whether geriatric assessment tool predict toxicity chemotherapy , define grade 3 4 toxicity , hospitalization , dose delay reduction , discontinuation chemotherapy due toxicity , elderly patient cancer . Secondary - Explore longitudinal impact cancer chemotherapy treatment geriatric assessment parameter . OUTLINE : Patients undergo assessment functional status use Timed Up Go Assessment ( measure physical mobility ) Karnofsky Physician-Rated Performance Rating Scale ; cognition use Blessed Orientation-Memory-Concentration Test . These assessment perform healthcare personnel . Body mass index percentage unintentional weight loss number fall past 6 month also assess . Patients also complete follow self-administered questionnaire : Instrumental Activities Daily Living ( measure level function need service ) ; Activities Daily Living ( measure high level physical functioning ) ; Karnofsky Self-Reported Performance Rating Scale ( related survival clinically significant illness ) ; Physical Health Section Older American Resources Services Questionnaire ( measure comorbidity impact daily activity ) ; Hospital Anxiety Depression Scale ; Medical Outcomes Study ( MOS ) Social Activity Limitations Measure ( measure impact cancer patient ' social functioning ) ; MOS Social Support Survey Emotional/Information Tangible Subscales ( measure perceive availability social support ) . Patients begin plan chemotherapy . After completion chemotherapy ( maximum 12 month study entry ) , patient undergo assessment complete self-administered questionnaire describe . PROJECTED ACCRUAL : A total 750 patient accrue study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Pathologically confirm cancer Receiving chemotherapy either adjuvant treatment metastatic disease prior begin new chemotherapy regimen PATIENT CHARACTERISTICS : Must able understand English PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior enrollment trial No concurrent enrollment phase I clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>cognitive/functional effect</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>